[1] SHAO HX. Recent research progress in human parvovirus B19infection[J]. Med Recapitulate, 2011, 17(20):3063-3066.(in Chinese)邵惠训.人类微小病毒B19感染的最新进展[J].医学综述,2011, 17(20):3063-3066.
|
[2] CORCORAN C, HARDIE D, YEATS J, et al. Genetic variants of human parvovirus B19 in South Africa:Cocirculation of three genotypes and identification of a novel subtype of genotype 1[J]. J Clin Microbiol, 2010, 48(1):137-142.
|
[3] JIANG M, LUO CB, ZHAN H, et al. Clinical characteristic analysis on anemia associated with human parvovirus B19 infection in liver transplant recipients[J]. Chin J Clin Med, 2018,25(3):405-408.(in Chinese)蒋密,罗楚彬,战昊,等.肝移植患者人类微小病毒B19感染与相关贫血的临床特点分析[J].中国临床医学,2018, 25(3):405-408.
|
[4] ABDOLLAHI A, SHOAR S, SHEIKHBAHAEI S, et al. Status of immunity against PVB19 in HIV-infected patients according to CD4(+)cel count, and antiretroviral therapy regimen groups[J].Niger Med J, 2014, 55(1):20-23.
|
[5] HUANG SL, YU LX, DENG WF, et al. Pure red cell aplasia caused by human parvovirus B19 infection after renal transplantation:A report of 2 cases and literature review[J]. Ogran Transplantation, 2015, 6(4):249-253.(in Chinese)黄森林,于立新,邓文锋,等.肾移植术后人类微小病毒B19感染致纯红细胞再生障碍性贫血2例并文献复习[J].器官移植,2015, 6(4):249-253.
|
[6] LI SY, SHEN B, LIU ZH, et al. Human parvovirus B 19-induced pure red cell aplasia in patients with al ograft renal transplantation[J]. Prog Mod Biomed, 2012, 12(14):2698-2702.(in Chinese)李帅阳,沈兵,刘志宏,等.肾移植术后人微小病毒B19感染导致纯红细胞增生障碍性贫血[J].现代生物医学进展,2012, 12(14):2698-2702.
|
[7] XIE EB, XUAN FH, SUN XD, et al. An analysis of risk factors for early complications after liver transplantation[J]. J Clin Hepatol, 2018, 34(6):1282-1288.(in Chinese)解恩博,轩凤慧,孙晓东,等.肝移植术后早期并发症的危险因素分析[J].临床肝胆病杂志,2018, 34(6):1282-1288.
|
[8] CHEN T, LI RD, YING Y, et al. Next generation sequencing screening for human parvovirus B19 infection after liver transplantation and the analysis of related risk factors[J]. Ogran Transplantation, 2019, 10(6):696-701.(in Chinese)陈拓,李瑞东,应悦,等.肝移植术后人类细小病毒B19感染的二代测序筛查及其相关危险因素分析[J].器官移植,2019, 10(6):696-701.
|
[9] LI DL, LIANG TB. Etiology and diagnosis and treatment of pure red cell aplasia after solid organ transplantation[J]. Natl Med J China, 2006, 86(42):3020-3022.(in Chinese)李栋林,梁廷波.实体器官移植后纯红细胞再生障碍性贫血的病因与诊治[J].中华医学杂志,2006, 86(42):3020-3022.
|
[10] CRABOL Y, TERRIER B, ROZENBERG F, et al. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection:A retrospective study of 10 patients and review of the literature[J]. Clin Infect Dis, 2013, 56(7):968-977.
|